tirzepatide is the same as mounjaro Semaglutide vs. for Weight Loss Mounjaro (Tirzepatide) for Medical Weight

Even patients who are not at risk of severe hypoglycemia (typically those who do not use insulin or sulfonylureas) may feel dizzy while experiencing transient low blood sugar episodes

Recently, the medication has also become very popular to address obesity, showing significant results in the long term

Regular follow-up appointments with your doctor are essential to monitor progress, review the need for continued medication, and provide ongoing support for long-term weight management

In pivotal trials, 63% of patients lost at least 5% of their body weight, with an average reduction of about 8% after approximately 56 weeks of treatment